ImmunoPrecise AI Discovers Pan-Serotype Dengue Vaccine Target Fully In Silico
ImmunoPrecise Antibodies Ltd. (IPA) reported an in silico discovery of a single, strictly conserved epitope across all four dengue virus …
News
Antheia Raises $56M Series C to Scale Biosynthetic Drug Ingredient Production, Expands to Asia
Menlo Park–based biomanufacturing company Antheia, founded in 2015 by Dr. Christina Smolke and Dr. Kristy Hawkins, announced a $56 million …
AI-Designed Drug Reaches Clinical Validation: Insilico’s Rentosertib in Nature Medicine
Today, Nature Medicine published peer-reviewed Phase IIa clinical results for Rentosertib (ISM001-055), a TNIK inhibitor developed by Insilico Medicine using a …
French Startup Using AI and Click Chemistry to Speed Up Microbial Detection Raises €5M
Diamidex, a Marseille-based company developing microbiological testing tools for industrial and environmental labs, has expanded the international reach of its …
BioAge Preps Brain-Penetrant NLRP3 Inhibitor for Obesity IND
BioAge Labs has finished the pre-clinical package for BGE-102, an orally available, brain-penetrant NLRP3 inhibitor that the company is advancing …
Insilico Medicine's AI Designs ENPP1 Inhibitor for Immune Modulation in Cancer
A study published in Nature Communications reports the development of ISM5939, an orally active small-molecule ENPP1 inhibitor designed using Insilico …
Medable Launches Digital Long-Term Follow-Up Model for Cell and Gene Therapy Trials
Medable, a U.S.-based provider of software infrastructure for decentralized clinical trials, has introduced a digital-first Long-Term Follow-Up (LTFU) model intended …
Finnish CurifyLabs Raises €6.7M to Replace Manual Compounding With Robotic Drug Manufacturing
CurifyLabs, a Finnish healthtech company, has raised €6.7 million to expand its automated solution for manufacturing compounded medications. The round was …
Biostate AI Raises $12M to Build RNA-Based Foundation Model for Molecular Diagnostics
Biostate AI has raised $12 million in Series A funding to scale its RNA sequencing platform and train a general-purpose …
Harvard and Roche Develop Foundation AI Model to Predict and Explain Immunotherapy Response Across 33 Cancer Types
Researchers from Harvard Medical School and Roche have developed COMPASS, a foundation AI model designed to predict patient response to …
Haya Therapeutics Raises $65M to Develop RNA Drugs Targeting the Dark Genome
Haya Therapeutics has raised $65 million in Series A financing to support development of therapies targeting long non-coding RNAs (lncRNAs), …
Persist AI Launches Robotic Cloud Lab for Formulation Development, Raises $12M Series A
Persist AI, a startup focused on accelerating pharmaceutical formulation development through AI-guided robotics, has launched its Cloud Lab platform and …